Introduction: Neuro Pro contains a powerful spectrum of nutrients specifically designed for their positive effect on neurological tissue. The clinical efficacy of these neuroactive compounds represents the cutting edge of scientific research into the treatment of neurological disorders and their associated behavioural abnormalities.

Each capsule contains:

L Tyrosine 400mg

DMAE (Dimethylaminoethanol) 200mg

N Acetyl Carnitine 50mg

Phosphatidylserine 15mg

NADH (Nicotinamide Adenine Dinucleotide Hydrogen) 1mg

Dosage: Take one or two tablets daily before food, or as directed by your health care practitioner.

Synergistic formula: Phosphatidylserine, Proxan, N Acetyl Carnitine.

Parkinsons Disease Neuropathies

Intelligence Hangovers

Insomnia Stress

Contraindications: Patients with Epilepsy should not use Neuro Pro unless they are monitored by a physician.

1. Attention Defect Disorder ( disorder).

Supplementation of DMAE has shown to significantly benefit children affected with disorder. Supplemental doses of DMAE around 300-3000mg per day has been shown to be effective in most treatment programs. DMAE increases Attention Span, decreases Aggression, improves Learning ability and increases Intelligence in 70% of disorder patients. DMAE also exerts a powerful calming effect on students. In a double blind placebo controlled cross over study students administered 1,200 mg of DMAE per day for 5 days exhibited better control of anxious reactivity under exam conditions.

A military study showed that Tyrosine can increase concentration in a prolonged work environment. Subjects were supplemented with Tyrosine and it was found that concentration time and quality was improved.

Supplemental, exogenous NADH improves concentration in humans. NADH enhances the production of energy and dopamine in the brain which improves the ability to focus on tasks.

Phosphatidylserine has a dynamic beneficial effect on disorder. For a complete profile of Phosphatidylserine’s therapeutic benefits, see the Tech Data on Phosphatidylserine.

Tyrosine is effective in treating Depression (by stimulating the production of Norepinephrine). One study showed that 6,000mg of tyrosine was 80% effective for totally relieving symptoms of depression after 2 weeks of supplementation.

N Acetyl Carnitine has found to significantly improve the outcome of depressed elderly patients. When dosages of 500-3000mg were given to elderly patients, significant improvement was noted in depression parameters.

Supplemental, exogenous NADH (5 mg per day) alleviates Depression (by boosting Brain Dopamine and Norepinephrine levels). 93% of 205 Depression patients improved in terms of their Depression symptoms after supplementation of NADH.

Phosphatidylserine has a beneficial effect on Depression. For a complete profile of Phosphatidylserine’s therapeutic benefits, see the Tech Data on Phosphatidylserine.

3. Alzheimer’s Disease.

Studies show significant promise for the use of NADH in the treatment of Alzheimer’s Disease. Supplemental, exogenous NADH (10 mg per day) improves the Memory of persons afflicted with Alzheimer’s Disease and retards the further progression of Alzheimer’s Disease (by enhancing the production of Energy within Neurons and by enhancing Dopamine production).

N Acetyl Carnitine (NAC) has an impressive list of medical studies showing its ability to improve the outcome of individuals afflicted with Alzheimer’s Disease. N Acetyl Carnitine improves Alertness, Attention Span and Short Term Memory in persons afflicted with Alzheimer's Disease and retards the further progression of Alzheimer's Disease using 2,000 - 3,000 mg of supplemental NAC per day for 3 months. Persons afflicted with Alzheimer’s Disease exhibited significantly less deterioration in Mental Function following the administration of supplemental NAC for 12 months. This finding was verified by using nuclear magnetic resonance on the subjects.

Phosphatidylserine has a dynamic beneficial effect on Alzheimer’s Disease. For a complete profile of Phosphatidylserine’s therapeutic benefits, see the Tech Data on Phosphatidylserine.

Conclusion :

Neuroactive nutrients represent an exciting advancement in the treatment of difficult to manage neurological disorders and their associated behavioral abnormalities. The synergistic use of these nutrients has provided even greater clinical responsiveness than the individual compounds themselves. Enhancing the repair and function of damaged neurological tissues is now more a reality than ever before.